By admin 
At present, Semler Scientific announced it has elevated its Bitcoin holdings. The corporate acquired 185 Bitcoin between Might 23 and June 3 for $20 million with a median buy worth of $107,974 per Bitcoin, utilizing proceeds from its at-the-market (ATM) providing program.
“We proceed to accretively develop our bitcoin arsenal utilizing working money circulate and proceeds from debt and fairness financings,” stated the chairman of Semler Scientific Eric Semler. “And we’re excited to launch the Semler Scientific dashboard at the moment on our web site to supply the general public with usually up to date data on our bitcoin holdings and different key metrics.”
Since launching the ATM program in April 2025, Semler has raised roughly $136.2 million beneath the gross sales settlement of over 3.6 million shares of its widespread inventory.
As of June 3, 2025, Semler holds 4,449 Bitcoin which have been acquired for an quantity of $410.0 million, with a median buy worth of $92,158 per Bitcoin. On the time of writing, the market worth of those holdings is round $446.2 million.
Eric Semler on X posted, “SMLR acquires 185 Bitcoins for $20 million and has generated BTC Yield of 26.7% YTD. Now holding 4,449 $BTC.”
Semler Scientific makes use of the BTC Yield as a key efficiency indicator (KPI) to assist assess the efficiency of its technique of buying Bitcoin. As of year-to-date, the corporate has achieved a BTC Yield of 26.7%.
“Semler Scientific believes this KPI can be utilized to complement an investor’s understanding of Semler Scientific’s determination to fund the acquisition of Bitcoin by issuing extra shares of its widespread inventory or devices convertible to widespread inventory,” acknowledged the 8-Okay kind.
In Q1 FY2025, Semler Scientific reported a tough quarter. Income got here in at $8.8 million, a 44% lower year-over-year. Working bills jumped to $39.9 million from $8.9 million final 12 months, primarily because of a $29.8 million contingent legal responsibility tied to the potential settlement with the DOJ. This led to a $31.1 million working loss, in comparison with a $7.0 million revenue in Q1 2024.
“Our healthcare enterprise is seeing inexperienced shoots from the cardiovascular product line that we launched to our massive enterprise buyer base this 12 months,” stated the CEO of Semler Scientific Doug Murphy-Chutorian. “We expect progress and money technology from these FDA-cleared services and products, which is able to add to our bitcoin treasury technique.”